SCHEMBL19082509

SCHEMBL19082509

Cc1ccc(-c2cc3ccccc3cc2F)c(C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.47
TDP1 Q9NUW8 2/20 0.47
CYP1A2 P05177 5/20 0.38
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
GRM2 Q14416 1/20 0.38
ELANE P08246 1/20 0.37
MBNL1 Q9NR56 1/20 0.37
AKR1C3 P42330 2/20 0.36
AKR1C2 P52895 2/20 0.36
MAPT P10636 2/20 0.36
GAA P10253 1/20 0.36
ACHE P22303 1/20 0.35
GLA P06280 1/20 0.34
NQO2 P16083 1/20 0.34
PSMB5 P28074 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14850866 0.79 ELANE (0.45) PDE3BPDE3AGRM2ELANEMBNL1
SCHEMBL19853585 0.79 PDE3B (0.40) CYP2A6TDP1CYP1A2PDE3BPDE3A
SCHEMBL12627935 0.75 MEN1 (0.46) TDP1PDE3BPDE3AMAPTGAA
SCHEMBL30069362 0.75 MEN1 (0.46) TDP1PDE3BPDE3AMAPTGAA
SCHEMBL31547677 0.74 TDP1 (0.52) CYP2A6TDP1CYP1A2ELANEMAPT
SCHEMBL3043421 0.74 TDP1 (0.52) CYP2A6TDP1CYP1A2ELANEMAPT
SCHEMBL15701854 0.74 CYP2A6 (0.42) CYP2A6TDP1CYP1A2ELANEMAPT
SCHEMBL11729295 0.73 ELANE (0.52) CYP2A6TDP1CYP1A2ELANEMAPT
SCHEMBL29590360 0.73 ELANE (0.52) CYP2A6TDP1CYP1A2ELANEMAPT
SCHEMBL26865675 0.72 MAPT (0.40) CYP2A6TDP1CYP1A2PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP2A6 2198/4885TDP1 2322/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.